Functional evaluation of prevascularization in one-stage versus two-stage tissue engineering approach of human bio-artificial muscle.


Journal

Biofabrication
ISSN: 1758-5090
Titre abrégé: Biofabrication
Pays: England
ID NLM: 101521964

Informations de publication

Date de publication:
12 06 2020
Historique:
pubmed: 2 5 2020
medline: 9 6 2021
entrez: 2 5 2020
Statut: epublish

Résumé

A common shortcoming of current tissue engineered constructs is the lack of a functional vasculature, limiting their size and functionality. Prevascularization is a possible strategy to introduce vascular networks in these constructs. It includes among others co-culturing target cells with endothelial (precursor) cells that are able to form endothelial networks through vasculogenesis. In this paper, we compared two different prevascularization approaches of bio-artificial skeletal muscle tissue (BAM) in vitro and in vivo. In a one-stage approach, human muscle cells were directly co-cultured with endothelial cells in 3D. In a two-stage approach, a one week old BAM containing differentiated myotubes was coated with a fibrin hydrogel containing endothelial cells. The obtained endothelial networks were longer and better interconnected with the two-stage approach. We evaluated whether prevascularization had a beneficial effect on in vivo perfusion of the BAM and improved myotube survival by implantation on the fascia of the latissimus dorsi muscle of NOD/SCID mice for 5 or 14 d. Also in vivo, the two-stage approach displayed the highest vascular density. At day 14, anastomosis of implanted endothelial networks with the host vasculature was apparent. BAMs without endothelial networks contained longer and thicker myotubes in vitro, but their morphology degraded in vivo. In contrast, maintenance of myotube morphology was well supported in the two-stage prevascularized BAMs. To conclude, a two-stage prevascularization approach for muscle engineering improved the vascular density in the construct and supported myotube maintenance in vivo.

Identifiants

pubmed: 32357347
doi: 10.1088/1758-5090/ab8f36
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

035021

Auteurs

D Gholobova (D)

Tissue Engineering Lab, Department of Development and Regeneration, KU Leuven, E. Sabbelaan 53, 8500, Kortrijk, Belgium.
These authors contributed equally.

L Terrie (L)

Tissue Engineering Lab, Department of Development and Regeneration, KU Leuven, E. Sabbelaan 53, 8500, Kortrijk, Belgium.
These authors contributed equally.

K Mackova (K)

Centre for Surgical Technologies, Group Biomedical Sciences, KU Leuven, Leuven, Belgium.
Department of Development and Regeneration, Woman and Child, Group Biomedical Sciences, KU Leuven, Leuven, Belgium.
Pelvic Floor Unit, University Hospitals KU Leuven, Leuven, Belgium.
Institute for the Care of Mother and Child, Third Faculty of Medicine, Charles University, Prague, Czech Republic.

L Desender (L)

Tissue Engineering Lab, Department of Development and Regeneration, KU Leuven, E. Sabbelaan 53, 8500, Kortrijk, Belgium.

G Carpentier (G)

Laboratoire de Recherche sur la Croissance Cellulaire, la Réparation et la Régénération Tissulaires (CRRET), Faculté des Sciences et Technologie, Université Paris-Est, 94000, Créteil, France.

M Gerard (M)

Tissue Engineering Lab, Department of Development and Regeneration, KU Leuven, E. Sabbelaan 53, 8500, Kortrijk, Belgium.

L Hympanova (L)

Centre for Surgical Technologies, Group Biomedical Sciences, KU Leuven, Leuven, Belgium.
Department of Development and Regeneration, Woman and Child, Group Biomedical Sciences, KU Leuven, Leuven, Belgium.
Pelvic Floor Unit, University Hospitals KU Leuven, Leuven, Belgium.
Institute for the Care of Mother and Child, Third Faculty of Medicine, Charles University, Prague, Czech Republic.

J Deprest (J)

Centre for Surgical Technologies, Group Biomedical Sciences, KU Leuven, Leuven, Belgium.
Department of Development and Regeneration, Woman and Child, Group Biomedical Sciences, KU Leuven, Leuven, Belgium.
Pelvic Floor Unit, University Hospitals KU Leuven, Leuven, Belgium.

L Thorrez (L)

Tissue Engineering Lab, Department of Development and Regeneration, KU Leuven, E. Sabbelaan 53, 8500, Kortrijk, Belgium.
Author to whom any correspondence should be addressed.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH